Explore UAB


Max AustinIt is with profound sadness that we announce the passing of J. Max Austin, Jr., M.D., a revered figure in the field of gynecologic oncology and a cherished member of the UAB Department of Obstetrics and Gynecology. Dr. Austin passed away on Wednesday, August 14, 2024, leaving behind a legacy of dedication, compassion, and excellence that will continue to inspire future generations of medical professionals.

Dr. Austin's journey began in Wetumpka, Alabama, where his roots and commitment to his home state shaped his illustrious career. After earning his bachelor's degree from Oxford College of Emory University in 1963, he returned to Alabama to receive his medical degree from the Medical College of Alabama (now UAB) in 1967. Following a year of residency training in Atlanta and two years of service in the Air Force, Dr. Austin embarked on a remarkable career that would span decades and impact countless lives.

He completed his OB/GYN residency and fellowship in gynecologic oncology at UAB, and his career in medicine has been a testament to his unwavering dedication to advancing the field and improving patient care. Dr. Austin's professional journey was marked by numerous milestones, including his role as Chief of Obstetrics and Gynecology at Homestead Air Force Base and his extensive practice at Southern Gynecologic Oncology in Birmingham, where he served patients for 23 years.

Charles A. Leath, III, M.D., MSPH, Division Director of Gynecologic Oncology and Ellen Gregg Shook Culverhouse Chair in Gynecologic Oncology, affirmed that Dr.  Austin was the consummate gentlemen, citizen and cancer surgeon that worked to ensure and provide excellent gynecologic cancer care to those across the state of Alabama and the Southeast.

In 2000, Dr. Austin returned to UAB, where he took on the role of full professor in the Division of Gynecologic Oncology. His return was celebrated with the establishment of the J. Max Austin, Jr., M.D. Endowed Chair in Gynecologic Oncology, a fitting tribute to his remarkable contributions to medicine and medical education.

“Dr. Austin contributed directly to the education of nearly 50 gynecologic oncology fellows at UAB,” said Leath, “including thankfully my own, and his teachings on surgical efficiency, novel surgical approaches and practice management are still followed to this day.”

His commitment to addressing the disparities in cancer care, particularly in Alabama, was a driving force in his career. Dr. Austin was vocal about the urgent need to educate and improve techniques in the detection and diagnosis of gynecologic malignancies, recognizing the critical importance of early intervention.

“In conjunction with leaders in Gynecologic Oncology at the University of Alabama at Birmingham,” said Leath, “Dr. Austin helped implement a system of combined private and academic gynecologic cancer care for the city of Birmingham and the state of Alabama which served as a model for other communities and institutions to emulate.”

J. Michael Straughn, Jr., M.D., UAB Medicine Chief of the Medical Staff and J. Max Austin Jr., M.D. Endowed Chair in Gynecologic Oncology, shared his sentiments:” Dr. Austin was an amazing physician, surgeon, teacher, and colleague. During his career, he taught countless residents and fellows the art of pelvic surgery. I will always remember the kindness and respect he had for his patients, their families, nurses, staff, and colleagues.”

Dr. Austin’s influence extended beyond his clinical and academic roles. He was honored with numerous accolades, reflecting his exceptional contributions to the field and to his community. Notable recognitions include the Health Care Hero Award by the Birmingham Business Journal, the Carl Chandler Alumnus Award from Oxford College of Emory University, and the Distinguished Alumnus Award from the Medical Alumni Association of the UAB Medical Center. His leadership extended nationally and was President of the Society of Gynecologic Oncology in 2002. Further, he was recognized as a 2015 Alabama Legend in Obstetrics/Gynecology by the Alabama section of ACOG. His commitment to teaching earned him several nominations and the award for best faculty teacher by the Argus Committee at UAB.

His dedication was also recognized by the Sigma Chi Fraternity, which honored him with the Significant Sig Award, and by the Elmore County 4-H Club, which presented him with a Lifetime Achievement Award.

Dr. Austin's legacy is defined by his relentless pursuit of excellence, his profound impact on the lives of his patients, and his dedication to mentoring and teaching the next generation of medical professionals. His contributions have left an indelible mark on the field of gynecologic oncology and on the UAB community.

Warner K. Huh, M.D., FACOG, FACS, MSHA, UAB Department of OB/GYN Chair, explained that Dr. Austin was a trailblazer in every sense of the word.

“He set the standard for how gynecologic oncology should be practiced, how to conduct oneself around patients and families, how to embrace and love your team, and how to be an asset and leader in one’s community,” said Huh. “In 2024, the UAB gynecologic oncology division still practices based on fundamentals taught by Dr. Austin. The same can be said for the dozens of gynecologic oncologists across the United States. He was loved by his fellows, residents and medical students and always comported himself with such grace and kindness. His surgical talents were second to none, and he was a champion of innovation and efficiency-two uniquely different traits.”

As we mourn the loss of Dr. J. Max Austin, Jr., we also celebrate his extraordinary life and career. His passion for his work and his commitment to improving patient care and medical education will continue to inspire all who knew him.

“The Department and Division will forever be indebted to his last legacy at UAB,” said Huh, “and we lost a true legend and a champion of women’s health and cancer care in Alabama.”

Our deepest condolences go out to his family, colleagues, and all those whose lives were touched by Dr. Austin’s remarkable contributions. He will be dearly missed but remembered with great respect and admiration.

  • Professional Milestones

    Professional Milestones

    1963 | Dr. Austin graduates from Emory University.

     1967 | Dr. Austin receives a Doctor of Medicine from the University of Alabama (UAB).

     1971 | Dr. Austin becomes chief resident at the School of Medicine at UAB.

     1971 | Dr. Austin serves as major and as Chief of Obstetrics and Gynecology at Homestead Air Force Base in Florida.

     1973 | Dr. Austin becomes a fellow in gynecologic oncology at UAB.

     2000 | Dr. Austin closes his private practice after 23 years to become a full-time professor in the Division of Gynecologic Oncology at UAB.

     2000 | The J. Max Austin Jr. Professorship of Gynecologic Oncology is established in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham, with Dr. Austin being its first recipient.

     2002 | Dr. Austin becomes President of Society of Gynecologic Oncology (SGO) 

     2005 | Dr. Austin is nominated by the Argus Committee (Medical Students) for best faculty teacher in the Department of Obstetrics and Gynecology at the UAB School of Medicine. He receives a nomination for two more years, and is selected in 2007.

     2006 | Dr. Austin is selected by the Birmingham Business Journal as a “Health Care Hero, Physician, and Provider.”

     2008 | Dr. Austin is selected by the Oxford College of Emory University of Board of Counselors for the Carl Chandler Alumnus Award, the highest alumnus award from Oxford College.

     2009 | Dr. Austin is nominated and selected for the Lifetime Achievement Award by the Elmore County 4-H Club.

     2010 | Dr. Austin is honored with an Endowed Chair in Gynecologic Oncology at UAB.

     2010 | Dr. Austin receives the MASA Award and the Paul W. Burleson Award in recognition of distinguished service to county, state and national physician organizations.

     2012 | Dr. Austin is selected as Significant Sig by the National Sigma Chi Fraternity, the highest award given to Sigma Chi alumni.

     2015 | Dr. Austin is selected as Significant Sig by the National Sigma Chi Fraternity, the highest award given to Sigma Chi alumni.

     2019 | Dr. Austin receives the Distinguished Alumnus Award from the Medical Alumni Association of the UAB Medical Center.

  • Scholarly Works

    Scholarly Works

    1. A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy
    2. SGO presidential address February 3, 2003
    3. Stage IC adenocarcinoma of the endometrium: Survival comparisons of surgically staged patients with and without adjuvant radiation therapy
    4. A phase I study of combined modality intraperitoneal radioimmunotherapy for ovarian cancer
    5. Conservative management of Stage I endometrial carcinoma after surgical staging
    6. Intraperitoneal radioimmunochemotherapy of ovarian cancer: A phase I study
    7. The society of gynecologic oncologists outcomes task force. Study of endometrial cancer: Initial experiences
    8. Surgical management of endometrial adenocarcinoma using laparoscopically assisted staging and treatment
    9. Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens
    10. Treatment of the small unruptured ectopic pregnancy: A cost analysis of methotrexate versus laparoscopy
    11. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling
    12. T2/3 vulva cancer: A case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy
      A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva
    13. Staging ovarian cancer diagnosed during laparoscopy: Accuracy rather than immediacy
    14. The groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients
    15. The validity and significance of substages of advanced ovarian cancer
    16. A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva
    17. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium
    18. Second-look laparotomy and salvage therapy: A research modality only?
    19. Primary surgical therapy of ovarian cancer: How much and when
    20. Intraperitoneal chromic phosphate in ovarian cancer: Risks and benefits
    21. Ureteral strictures and fistulae following radical hysterectomy

    22. Cervical choriocarcinoma associated with an intrauterine contraceptive device: A case report
    23. Hemodynamic parameters following pelvic exenteration
    24. Urinary diversion in patients undergoing pelvic exenteration
    25. Verrucous lesions of the female genitalia. I. Giant condylomata
    26. Verrucous lesions of the female genitalia. II. Verrucous carcinoma
    27. Trophoblastic disease in Alabama.
    28. Acute pulmonary edema associated with molar pregnancies: A high-risk factor for development of persistent trophoblastic disease
    29. Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the presidential panel at the 1979 Annual Meeting of the Society of Gynecologic Oncologists
    30. Colposcopy or cervical conization? An economic comparison
    31. Folate-induced regression of cervical dysplasia in users of oral contraceptive agents (OCA)
    32. What the gynecologist expects from the pathology report.
    33. The significance of age in the colposcopic evaluation of women with atypical papanicolaou smears
    34. Outpatient evaluation of patients with atypical Papanicolaou smears: Contribution of endocervical curettage
    35. A classification of endocervical curettings
    36. 'The abnormal Pap smear' and its evaluation. The modern approach
    37. The contribution of endocervical smears to cervical cancer detection